Fidelity Investments’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$146M Buy
4,829,154
+289,929
+6% +$9.38M 0.01% 1005
2025
Q4
$158M Buy
4,539,225
+118,822
+3% +$4.19M 0.01% 970
2025
Q3
$161M Sell
4,420,403
-435,369
-9% -$14.8M 0.01% 945
2025
Q2
$152M Buy
4,855,772
+15,276
+0.3% +$475K 0.01% 936
2025
Q1
$144M Buy
4,840,496
+22,797
+0.5% +$684K 0.01% 940
2024
Q4
$142M Sell
4,817,699
-18,341
-0.4% -$580K 0.01% 970
2024
Q3
$151M Buy
4,836,040
+23,436
+0.5% +$852K 0.01% 933
2024
Q2
$163M Buy
4,812,604
+500,460
+12% +$25.5M 0.01% 854
2024
Q1
$280M Buy
4,312,144
+2,615,758
+154% +$180M 0.02% 657
2023
Q4
$116M Sell
1,696,386
-439,837
-21% -$22.9M 0.01% 956
2023
Q3
$111M Buy
2,136,223
+90,116
+4% +$5.33M 0.01% 924
2023
Q2
$123M Sell
2,046,107
-43,444
-2% -$2.48M 0.01% 906
2023
Q1
$103M Buy
2,089,551
+85,638
+4% +$4.82M 0.01% 976
2022
Q4
$114M Buy
2,003,913
+610,679
+44% +$34.4M 0.01% 921
2022
Q3
$65.4M Buy
1,393,234
+32,850
+2% +$1.57M 0.01% 1133
2022
Q2
$50.8M Sell
1,360,384
-267,171
-16% -$8.68M 0.01% 1254
2022
Q1
$48.7M Sell
1,627,555
-495,772
-23% -$12.5M ﹤0.01% 1399
2021
Q4
$72.7M Sell
2,123,327
-57,659
-3% -$2.09M 0.01% 1262
2021
Q3
$80.8M Buy
2,180,986
+949,142
+77% +$32M 0.01% 1195
2021
Q2
$48.1M Sell
1,231,844
-189,293
-13% -$7.31M ﹤0.01% 1453
2021
Q1
$60.5M Buy
+1,421,137
New +$63.3M 0.01% 1305

Other funds holding IMCR